Granulocyte-mobilized bone marrow

Current Opinion in Hematology

Volumn 19, Issue 6, 2012, Pages 448-453

  Arcese, William ^a   De Angelis, Gottardo ^a   Cerretti, Raffaella ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

allogeneic stem cell transplantation; granulocyte colony stimulating factor primed bone marrow; haploidentical hematopoietic stem cell donor

Indexed keywords

BASILIXIMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; BONE MARROW; BONE MARROW TRANSPLANTATION; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMORBIDITY; CYTOKINE PRODUCTION; DONOR; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA REMISSION; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84868203170     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32835903ab     Document Type: Review

References (36)

1. Körbling M, Freireich EJ. Twenty-five years of peripheral blood stem cell transplantation. Blood 2011; 117:6411-6416.
2. Schmitz N, Beksac M, Hasenclever D, et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100:761-767.
3. Ringdén O, Labopin M, Beelen DW, et al. Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adults patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients. J Intern Med 2012 doi: 10.1111/j.1365-2796.2012.02547.x. [Epub ahead of print]
4. Shier LR, Schultz KR, Imren S, et al. Differential effects of granulocyte colonystimulating factor on marrow and blood derived hematopoietic and immune cell populations in healthy human donors. Biol Blood Marrow Transplant 2004; 10:624-634.
5. Chang Y-J, Zhao X-Y, Huo M-R, Huang X-J. Expression profiles of adhesion molecules on na?̈ve T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor. Transpl Immunol 2009; 21:228-233.
6. Huang X-J, Chang Y-J, Zhao X-Y. In-vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 2004; 89:1517-1524.
7. Huang X-J, Chang Y-J, Zhao X-Y. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Haematologica 2005; 90:715-716.
8. Mielcareck M, Martin PJ, Torok-Storb B. Suppression of alloantigeninduced T-cell proliferation by CD14+ cells derived from granulocyte colonystimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89:1629-1634.
9. Arpinati M, Green CL, Heimfeld S, et al. Granulocyte-colony stimulating factors mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484-2490.
10. Anderlini P, Champlin RE. Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 2008; 111:1767-1772.
11. Koyama M, Hashimoto D, Aoyama K, et al. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. Blood 2009; 113:2088-2095.
12. Chang Y-J, Huang X-J. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin Transplant 2011; 25:13-23.
13. Isola L, Scigliano E, Fruchtman S. Long-term follow-up after allogeneic granulocyte colony-stimulating-factor primed bone marrow transplantation. Biol Blood Marrow Transplant 2000; 6:428-433.
14. Couban S, Messner HA, Andreou P, et al. Bone marrow mobilized with granulocyte colony-stimulating-factor in related allogeneic transplant recipients: a study of 29 patients. Biol Blood Marrow Transplant 2000; 6:422-427.
15. Ji SQ, Chen HR, Wang HX, et al. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulatingfactor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 2002; 8:261-267.
16. Chiang KY, Haight A, Horan J, et al. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colonystimulating-factor primed bone marrow and steady-state bone marrow. Pediatr Transplant 2007; 11:279-285.
17. Ji S-Q, Chen H-R, Xun C-Q, et al. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation. Clin Transplant 2001; 15:317-323.
18. Serody JS, Sparks SD, Lin Y, et al. Comparison of granulocyte colonystimulating-factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000; 6:434-444.
19. Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001; 98:3186-3191.
20. Ostronoff F, Ostronoff M, Souto-Maior AP, et al. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies. Clin Transplant 2009; 23:33-38.
21. Frangoul H, Nemecek ER, Billheimer D, et al. A prospective study of G-CSFprimed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood 2007; 110:4584-4587.
22. Kim H-J, Min W-S, Cho B-S, et al. Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML. Bone Marrow Transplant 2009; 44:345-351.
23. Arcese W, Mangione I, Picardi A. Algorithm for donor selection in 2011. Curr Opin Hematol 2011; 18:401-407.
24. Ballen KK, Koreth J, Chen YB, et al. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood 2012; 119:1972-1980.
25. Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood 2011; 118:6006-6017.
26. Ji S-Q, Chen H-R, Wang H-X, et al. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Transplant 2002; 30:861-866.
27. Chen H-R, Ji S-Q, Wang H-X, et al. Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-versus-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion. Exp Hematol 2003; 31:1019-1025.
28. Ji S-Q, Chen H-R, Yan H-M, et al. Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for haematological malignancies. Bone Marrow Transplant 2005; 36:349-354.
29. Wang H-X, Yan H-M, Duan L-N, et al. Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases. Pediatr Hematol Oncol 2009; 26:119-128.
30. Wang H-X, Yan H-M, Liu J, et al. Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement. Leuk Lymphoma 2009; 50:1488-1493.
31. Huang X-J, Xu L-P, Liu K-Y, et al. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematological malignancies. Clin Cancer Res 2009; 15:4777-4783.
32. Lu D-P, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006; 107:3065-3073.
33. Chen X-H, Zhang C, Zhang X, et al. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant 2009; 15:266-273.
34. Huang X-J, Chang Y-J. Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation. Biol Blood Marrow transplant 2011; 17:197-204.
35. De Angelis G, Santarone S, Cerretti R, et al. Non T-cell depleted, G-CSF primed bone marrow transplantation from haploidentical donors for patients with high-risk acute myeloid leukaemia. 37th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2011; 46 (1s):S39.
36. De Angelis G, Santarone S, Cudillo L, et al. Reduced-intensity conditioning regimen followed by non T-cell depleted, G-CSF primed bone marrow transplantation from haploidentical donors for adults patients with high-risk acute myeloid leukaemia. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012; 47: S94.